DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 124 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2017. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $867,413 | +29.4% | 58,728 | +13.2% | 0.01% | +40.0% |
| Q2 2023 | $670,483 | +337.3% | 51,895 | +232.0% | 0.01% | +400.0% |
| Q1 2023 | $153,340 | -45.7% | 15,631 | -41.1% | 0.00% | -50.0% |
| Q4 2022 | $282,513 | +5.0% | 26,552 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $269,000 | -61.1% | 25,800 | -53.1% | 0.00% | -60.0% |
| Q2 2022 | $692,000 | -59.8% | 54,989 | -60.4% | 0.01% | -54.5% |
| Q3 2018 | $1,720,000 | -5.4% | 138,719 | +16.2% | 0.01% | -8.3% |
| Q2 2018 | $1,819,000 | -18.4% | 119,336 | +6.3% | 0.01% | +140.0% |
| Q1 2018 | $2,228,000 | +13.8% | 112,278 | +7.2% | 0.01% | 0.0% |
| Q4 2017 | $1,958,000 | -16.5% | 104,756 | -3.9% | 0.01% | -16.7% |
| Q3 2017 | $2,345,000 | – | 109,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |